Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)
====================================================================================================================================================================

* Michael B Atkins
* Opeyemi A Jegede
* Naomi B Haas
* David F McDermott
* Mehmet A Bilen
* Mark Stein
* Jeffrey A Sosman
* Robert Alter
* Elizabeth R Plimack
* Moshe C Ornstein
* Michael Hurwitz
* David J Peace
* Sabina Signoretti
* Thomas Denize
* Alessia Cimadamore
* Catherine J Wu
* David Braun
* David Einstein
* Paul J Catalano
* Hans Hammers